414 related articles for article (PubMed ID: 28810904)
1. Antiarrhythmic drug therapy among patients presenting to emergency department with symptomatic atrial fibrillation - a prospective nationwide cohort.
Penttilä T; Mäkynen H; Hartikainen J; Hyppölä H; Lauri T; Lehto M; Lund J; Raatikainen MJP;
Scand J Trauma Resusc Emerg Med; 2017 Aug; 25(1):81. PubMed ID: 28810904
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
Lévy S
Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulation therapy among patients presenting to the emergency department with symptomatic atrial fibrillation - the FinFib2 study.
Penttilä T; Mäkynen H; Hartikainen J; Lauri T; Lehto M; Lund J; Mäkijärvi M; Raatikainen P
Eur J Emerg Med; 2017 Oct; 24(5):347-352. PubMed ID: 27097066
[TBL] [Abstract][Full Text] [Related]
4. Association Between Obesity-Mediated Atrial Fibrillation and Therapy With Sodium Channel Blocker Antiarrhythmic Drugs.
Ornelas-Loredo A; Kany S; Abraham V; Alzahrani Z; Darbar FA; Sridhar A; Ahmed M; Alamar I; Menon A; Zhang M; Chen Y; Hong L; Konda S; Darbar D
JAMA Cardiol; 2020 Jan; 5(1):57-64. PubMed ID: 31774463
[TBL] [Abstract][Full Text] [Related]
5. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
[TBL] [Abstract][Full Text] [Related]
6. Real-World Comparison of Classes IC and III Antiarrhythmic Drugs as an Initial Rhythm Control Strategy in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study.
Kipp R; Askari M; Fan J; Field ME; Turakhia MP
JACC Clin Electrophysiol; 2019 Feb; 5(2):231-241. PubMed ID: 30784696
[TBL] [Abstract][Full Text] [Related]
7. The epidemiology and management of recent-onset atrial fibrillation and flutter presenting to the Emergency Department.
Hamilton A; Clark D; Gray A; Cragg A; Grubb N;
Eur J Emerg Med; 2015 Jun; 22(3):155-61. PubMed ID: 25203594
[TBL] [Abstract][Full Text] [Related]
8. Clinical effectiveness of a systematic "pill-in-the-pocket" approach for the management of paroxysmal atrial fibrillation.
Andrade JG; MacGillivray J; Macle L; Yao RJR; Bennett M; Fordyce CB; Hawkins N; Krahn A; Jue J; Ramanathan K; Tsang T; Gin K; Deyell MW
Heart Rhythm; 2018 Jan; 15(1):9-16. PubMed ID: 29304952
[TBL] [Abstract][Full Text] [Related]
9. The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation.
Le Heuzey JY; Breithardt G; Camm J; Crijns H; Dorian P; Kowey PR; Merioua I; Prystowsky EN; Schwartz PJ; Torp-Pedersen C; Weintraub W
Am J Cardiol; 2010 Mar; 105(5):687-93. PubMed ID: 20185018
[TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmic strategies in patients with atrial fibrillation managed by cardiologists and internists: Antithrombotic Agents in Atrial Fibrillation (ATA-AF) survey.
Berisso MZ; Fabbri G; Gonzini L; Caruso D; Fontanella A; Pellegrini F; Silvestri N; Vincenti A; Mathieu G; Di Pasquale G;
J Cardiovasc Med (Hagerstown); 2014 Aug; 15(8):626-35. PubMed ID: 24978662
[TBL] [Abstract][Full Text] [Related]
11. Guideline-Concordant Antiarrhythmic Drug Use in the Get With The Guidelines-Atrial Fibrillation Registry.
Field ME; Holmes DN; Page RL; Fonarow GC; Matsouaka RA; Turakhia MP; Lewis WR; Piccini JP;
Circ Arrhythm Electrophysiol; 2021 Feb; 14(2):e008961. PubMed ID: 33419385
[TBL] [Abstract][Full Text] [Related]
12. Inappropriate use of antiarrhythmic drugs in paroxysmal and persistent atrial fibrillation in a large contemporary international survey: insights from RealiseAF.
Chiang CE; Goethals M; O'Neill JO; Naditch-Brûlé L; Brette S; Gamra H; Zharinov O; Steg PG;
Europace; 2013 Dec; 15(12):1733-40. PubMed ID: 23858023
[TBL] [Abstract][Full Text] [Related]
13. Physician stated atrial fibrillation management in light of treatment guidelines: data from an international, observational prospective survey.
Kowey PR; Breithardt G; Camm J; Crijns H; Dorian P; Le Heuzey JY; Pedrazzini L; Prystowsky EN; Salette G; Schwartz PJ; Torp-Pedersen C; Weintraub W
Clin Cardiol; 2010 Mar; 33(3):172-8. PubMed ID: 20235224
[TBL] [Abstract][Full Text] [Related]
14. Management of atrial fibrillation in the emergency room and in the cardiology ward: the BLITZ AF study.
Gulizia MM; Cemin R; Colivicchi F; De Luca L; Di Lenarda A; Boriani G; Di Pasquale G; Nardi F; Scherillo M; Lucci D; Fabbri G; Maggioni AP;
Europace; 2019 Feb; 21(2):230-238. PubMed ID: 30060174
[TBL] [Abstract][Full Text] [Related]
15. Progression of atrial fibrillation after a failed initial ablation procedure in patients with paroxysmal atrial fibrillation: a randomized comparison of drug therapy versus reablation.
Pokushalov E; Romanov A; De Melis M; Artyomenko S; Baranova V; Losik D; Bairamova S; Karaskov A; Mittal S; Steinberg JS
Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):754-60. PubMed ID: 23748210
[TBL] [Abstract][Full Text] [Related]
16. Current practice of antiarrhythmic drug therapy for prevention of atrial fibrillation in Europe: The European Heart Rhythm Association survey.
Dagres N; Lewalter T; Lip GY; Pison L; Proclemer A; Blomström-Lundqvist C;
Europace; 2013 Apr; 15(4):478-81. PubMed ID: 23530117
[TBL] [Abstract][Full Text] [Related]
17. Assessment of physician compliance to the CAEP 2021 Atrial Fibrillation Best Practices Checklist for rate and rhythm control in the emergency department.
Mattice AMS; Adler S; Eagles D; Yadav K; Hui S; Azward A; Pandey N; Stiell IG
CJEM; 2024 May; 26(5):333-338. PubMed ID: 38519830
[TBL] [Abstract][Full Text] [Related]
18. [Temporal evolution of treatment of patients with atrial fibrillation in a urban health care area].
Fuenzalida C; Coll-Vinent B; Navarro M; Cervera Á; Camafort M; Mont L;
Med Clin (Barc); 2015 Jun; 144(11):483-6. PubMed ID: 24747026
[TBL] [Abstract][Full Text] [Related]
19. Diltiazem versus metoprolol for rate control in atrial fibrillation with rapid ventricular response in the emergency department.
Hines MC; Reed BN; Ivaturi V; Bontempo LJ; Bond MC; Hayes BD
Am J Health Syst Pharm; 2016 Dec; 73(24):2068-2076. PubMed ID: 27919874
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
